BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 16639734)

  • 1. Impact of age on outcome of pediatric acute myeloid leukemia: a report from 2 institutions.
    Razzouk BI; Estey E; Pounds S; Lensing S; Pierce S; Brandt M; Rubnitz JE; Ribeiro RC; Rytting M; Pui CH; Kantarjian H; Jeha S
    Cancer; 2006 Jun; 106(11):2495-502. PubMed ID: 16639734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of age in acute myeloid leukemia patients younger than 30 years: a common analysis of the pediatric trials AML-BFM 93/98 and the adult trials AMLCG 92/99 and AMLSG HD93/98A.
    Creutzig U; Büchner T; Sauerland MC; Zimmermann M; Reinhardt D; Döhner H; Schlenk RF
    Cancer; 2008 Feb; 112(3):562-71. PubMed ID: 18076087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of myeloperoxidase expression in childhood acute myeloid leukemia.
    Roberson JR; Onciu M; Pounds S; Rubnitz JE; Pui CH; Razzouk BI
    Pediatr Blood Cancer; 2008 Mar; 50(3):542-8. PubMed ID: 17763467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of childhood myelodysplastic syndrome, AML FAB M6 or M7, CCG 2891: report from the Children's Oncology Group.
    Barnard DR; Alonzo TA; Gerbing RB; Lange B; Woods WG;
    Pediatr Blood Cancer; 2007 Jul; 49(1):17-22. PubMed ID: 16856158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and biologic features and treatment outcome of children with newly diagnosed acute myeloid leukemia and hyperleukocytosis.
    Inaba H; Fan Y; Pounds S; Geiger TL; Rubnitz JE; Ribeiro RC; Pui CH; Razzouk BI
    Cancer; 2008 Aug; 113(3):522-9. PubMed ID: 18484648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors and outcome of recurrence in childhood acute myeloid leukemia.
    Rubnitz JE; Razzouk BI; Lensing S; Pounds S; Pui CH; Ribeiro RC
    Cancer; 2007 Jan; 109(1):157-63. PubMed ID: 17133407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telomerase activity is prognostic in pediatric patients with acute myeloid leukemia: comparison with adult acute myeloid leukemia.
    Verstovsek S; Manshouri T; Smith FO; Giles FJ; Cortes J; Estey E; Kantarjian H; Keating M; Jeha S; Albitar M
    Cancer; 2003 May; 97(9):2212-7. PubMed ID: 12712473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repetitive cycles of high-dose cytarabine are effective for childhood acute myeloid leukemia: long-term outcome of the children with AML treated on two consecutive trials of Tokyo Children's Cancer Study Group.
    Tomizawa D; Tabuchi K; Kinoshita A; Hanada R; Kigasawa H; Tsukimoto I; Tsuchida M;
    Pediatr Blood Cancer; 2007 Aug; 49(2):127-32. PubMed ID: 16807916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors and therapy for isolated central nervous system relapse of pediatric acute myeloid leukemia.
    Johnston DL; Alonzo TA; Gerbing RB; Lange BJ; Woods WG
    J Clin Oncol; 2005 Dec; 23(36):9172-8. PubMed ID: 16361619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Death during induction therapy and first remission of acute leukemia in childhood: the St. Jude experience.
    Rubnitz JE; Lensing S; Zhou Y; Sandlund JT; Razzouk BI; Ribeiro RC; Pui CH
    Cancer; 2004 Oct; 101(7):1677-84. PubMed ID: 15378506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Splenic rupture in children with hematologic malignancies.
    Athale UH; Kaste SC; Bodner SM; Ribeiro RC
    Cancer; 2000 Jan; 88(2):480-90. PubMed ID: 10640983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matched unrelated or matched sibling donors result in comparable survival after allogeneic stem-cell transplantation in elderly patients with acute myeloid leukemia: a report from the cooperative German Transplant Study Group.
    Schetelig J; Bornhäuser M; Schmid C; Hertenstein B; Schwerdtfeger R; Martin H; Stelljes M; Hegenbart U; Schäfer-Eckart K; Füssel M; Wiedemann B; Thiede C; Kienast J; Baurmann H; Ganser A; Kolb HJ; Ehninger G
    J Clin Oncol; 2008 Nov; 26(32):5183-91. PubMed ID: 18768435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of prognostic variables in childhood acute myeloid leukemia].
    Gu LJ; Tie LJ; Xue HL; Tang JY; Chen J; Pan C; Chen J; Ye H; Wang YP; Dong L
    Zhonghua Xue Ye Xue Za Zhi; 2006 Jan; 27(1):10-3. PubMed ID: 16732931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reproductive history, infertility treatment, and the risk of acute leukemia in children with down syndrome: a report from the Children's Oncology Group.
    Puumala SE; Ross JA; Olshan AF; Robison LL; Smith FO; Spector LG
    Cancer; 2007 Nov; 110(9):2067-74. PubMed ID: 17849462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Residual disease monitoring in childhood acute myeloid leukemia by multiparameter flow cytometry: the MRD-AML-BFM Study Group.
    ; Langebrake C; Creutzig U; Dworzak M; Hrusak O; Mejstrikova E; Griesinger F; Zimmermann M; Reinhardt D
    J Clin Oncol; 2006 Aug; 24(22):3686-92. PubMed ID: 16877738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study of clinical outcome and analysis of prognosis related factor in children with acute myeloid leukemia].
    Zou Y; Wang H; Chen XJ; Wang SC; Zhang L; Chen YM; Zhu XF
    Zhonghua Xue Ye Xue Za Zhi; 2006 Sep; 27(9):621-5. PubMed ID: 17278430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absolute lymphocyte count is a novel prognostic indicator in ALL and AML: implications for risk stratification and future studies.
    De Angulo G; Yuen C; Palla SL; Anderson PM; Zweidler-McKay PA
    Cancer; 2008 Jan; 112(2):407-15. PubMed ID: 18058809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of prognostic factors in ewing sarcoma family of tumors: review of St. Jude Children's Research Hospital studies.
    Rodríguez-Galindo C; Liu T; Krasin MJ; Wu J; Billups CA; Daw NC; Spunt SL; Rao BN; Santana VM; Navid F
    Cancer; 2007 Jul; 110(2):375-84. PubMed ID: 17569105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk-stratified therapy and the intensive use of cytarabine improves the outcome in childhood acute myeloid leukemia: the AML99 trial from the Japanese Childhood AML Cooperative Study Group.
    Tsukimoto I; Tawa A; Horibe K; Tabuchi K; Kigasawa H; Tsuchida M; Yabe H; Nakayama H; Kudo K; Kobayashi R; Hamamoto K; Imaizumi M; Morimoto A; Tsuchiya S; Hanada R
    J Clin Oncol; 2009 Aug; 27(24):4007-13. PubMed ID: 19620491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wilms tumor 1 gene mutations are associated with a higher risk of recurrence in young adults with acute myeloid leukemia: a study from the Acute Leukemia French Association.
    Renneville A; Boissel N; Zurawski V; Llopis L; Biggio V; Nibourel O; Philippe N; Thomas X; Dombret H; Preudhomme C
    Cancer; 2009 Aug; 115(16):3719-27. PubMed ID: 19536888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.